Publication | Closed Access

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

Emetogenic ChemotherapiesOncologyChemotherapy-induced NauseaGastrointestinal OncologyPharmacologyGastroenterologyTumor TypesPharmacotherapyCancer TreatmentMedicineRadiation OncologyCancer Research